| Active substance |
Dapoxetine, Tadalafil Citrate |
| Also known as |
LY-210448 |
| Blood pressure |
Can cause slight orthostatic hypotension (drop in blood pressure when standing up) |
| Chemical name |
(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine |
| Dosage (medical) |
Typically 30 mg or 60 mg taken 1-3 hours before sexual activity |
| Dosage (sports) |
Not applicable |
| Effects |
Increases time to ejaculation and improves control over ejaculation |
| Formula |
C21H23NO |
| Half-life |
1.31 hours |
| Hepatotoxicity |
Minimal |
| Lab Test |
Not specifically monitored in standard drug tests |
| Main action |
Inhibits serotonin transporter, increasing serotonin's action at pre- and postsynaptic receptors |
| Side effects |
Dizziness, headache, nausea, diarrhea, insomnia, fatigue |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Selective Serotonin Reuptake Inhibitor (SSRI) |
| Trade name |
Priligy |
| Use in sports |
None |
| Active ingredient, mg |
100 |
| Release form |
Pills |
| 1 Pill, mg |
100 |
| Blister, pills |
1, 10 |
| Manufacturer |
Elbrus Pharmaceuticals |
| Packing |
Blister (10 Pills) |
